Literature DB >> 2972249

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis.

M Chofflon1, H L Weiner, C Morimoto, D A Hafler.   

Abstract

A consistent immunological finding in patients with progressive multiple sclerosis is a loss of functional suppression. We have recently found decreases in suppressor inducer T cells in progressive multiple sclerosis as measured by two-color immunofluorescence using differentiation markers CD4 and 2H4. In the present study, we examined the relationship between functional suppression and circulating CD4+ 2H4+ T cells using a two-stage assay. (1) T cells were stimulated for 7 days with irradiated non-T cells (autologous mixed lymphocyte reaction [AMLR]) and harvested. It has previously been shown that suppressor T cells are generated during the course of the AMLR. (2) The AMLR-generated suppressor T cells were then incubated with mononuclear cells plus pokeweed mitogen, and immunoglobulin (Ig) synthesis was measured. There was less AMLR-induced suppression of IgG synthesis in patients with progressive multiple sclerosis as compared with normal subjects and patients with other neurological diseases. More importantly, there were significant correlations between decreases in circulating CD4+ 2H4+ cells and the AMLR (p = 0.009). Thus, the decreases in functional suppression and the decreases in the AMLR in multiple sclerosis appear tightly linked to CD4+ 2H4+ cells, and their measurement provides a means to monitor suppressor function phenotypically. Decreases in suppressor inducer T cells may in part explain immunoregulatory abnormalities observed in multiple sclerosis.

Entities:  

Mesh:

Year:  1988        PMID: 2972249     DOI: 10.1002/ana.410240203

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis.

Authors:  M Zaffaroni; S Rossini; A Ghezzi; R Parma; C L Cazzullo
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

Review 2.  Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.

Authors:  S F Hunter; M Rodriguez
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Evidence for a missed signal to the CD8+ cells in CSF of multiple sclerosis patients.

Authors:  M Saresella; A Grope; L Speciale; R Mancuso; R De Benedictis; D Caputo; P Ferrante
Journal:  Ital J Neurol Sci       Date:  1995-10

4.  Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression?

Authors:  A Salmaggi; A Dufour; M Eoli; E Corsini; L La Mantia; G Massa; A Nespolo; C Milanese
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

5.  Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis.

Authors:  F E Munschauer; C Stewart; L Jacobs; S Kaba; Z Ghorishi; S J Greenberg; D Cookfair
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

6.  Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.

Authors:  B Crucian; P Dunne; H Friedman; R Ragsdale; S Pross; R Widen
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

7.  Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.

Authors:  A Melms; G Malcherek; U Gern; N Sommer; R Weissert; H Wiethölter; H J Bühring
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

8.  Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity.

Authors:  M Eoli; M Ferrarini; A Dufour; S Heltaj; L Bevilacqua; G Comi; V Cosi; G Filippini; V Martinelli; C Milanese
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

9.  Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection.

Authors:  Y Iwasaki; Y Ohara; I Kobayashi; S Akizuki
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

10.  Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.

Authors:  K E Balashov; S J Khoury; D A Hafler; H L Weiner
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.